WELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing

Dow Jones

2025/03/31

By Adriano Marchese

WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies.

Shares fell over 24% to 3.77 Canadian dollars ($2.63).

The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings.

The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline.

Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors.

"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative," Krishnaratne said in a report.

WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

March 31, 2025 10:33 ET (14:33 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2523923646"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2523923646\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2523923646?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-31 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2523923646","market":"us","top_or_hot":-1,"title":"WELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre>\n \n</pre>\n<p>\n  WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies. \n</p>\n<p>\n  Shares fell over 24% to 3.77 Canadian dollars ($2.63). \n</p>\n<p>\n  The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings. \n</p>\n<p>\n  The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline. \n</p>\n<p>\n  Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors. \n</p>\n<p>\n  \"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative,\" Krishnaratne said in a report. \n</p>\n<p>\n  WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 31, 2025 10:33 ET (14:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-31 22:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre>\n \n</pre>\n<p>\n  WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies. \n</p>\n<p>\n  Shares fell over 24% to 3.77 Canadian dollars ($2.63). \n</p>\n<p>\n  The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings. \n</p>\n<p>\n  The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline. \n</p>\n<p>\n  Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors. \n</p>\n<p>\n  \"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative,\" Krishnaratne said in a report. \n</p>\n<p>\n  WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 31, 2025 10:33 ET (14:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2523923646","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2523923646","pubTimestamp":1743431580,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies.Shares fell over 24% to 3.77 Canadian dollars .The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings.The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline.Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors.\"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and dela","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","WELL":"WELLTOWER OP LLC","BK4203":"医疗保健房地产投资信托","BK4225":"医疗保健房地产信托"},"translate_title":"美国子公司调查推迟全年申报，WELL Health Technologies股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WELL":1},"content_text":"By Adriano Marchese \n\n\n \n\n\n  WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies. \n\n\n  Shares fell over 24% to 3.77 Canadian dollars ($2.63). \n\n\n  The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings. \n\n\n  The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline. \n\n\n  Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors. \n\n\n  \"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative,\" Krishnaratne said in a report. \n\n\n  WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 10:33 ET (14:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}